{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:29:40Z","timestamp":1791404980146,"version":"4.3.3"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00293","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T01:12:50Z","timestamp":1588900370000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":74,"title":["Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management"],"prefix":"10.3389","volume":"11","author":[{"given":"Alison M.","family":"Boyce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Roszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel I.","family":"Gafni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest."},{"key":"B2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bone.2015.12.055","article-title":"Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition","volume":"84","author":"Yamamoto","year":"2016","journal-title":"Bone."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.kint.2017.11.018","article-title":"Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury","volume":"93","author":"Toro","year":"2018","journal-title":"Kidney Int."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.01.006","article-title":"Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting","volume":"153865","author":"Bacchetta","year":"2019","journal-title":"Metabolism"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.1073\/pnas.1402218111","article-title":"Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis","volume":"111","author":"Tagliabracci","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"18370","DOI":"10.1074\/jbc.M602469200","article-title":"Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation","volume":"281","author":"Kato","year":"2006","journal-title":"J Biol Chem."},{"key":"B7","article-title":"Hyperphosphatemic familial tumoral calcinosis","volume-title":"GeneReviews(R).","author":"Ramnitz","year":"1993"},{"key":"B8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ng1358","article-title":"Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis","volume":"36","author":"Topaz","year":"2004","journal-title":"Nat Genetics."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1210\/jc.2004-2302","article-title":"A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive","volume":"90","author":"Ichikawa","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia","volume":"14","author":"Benet-Pages","year":"2005","journal-title":"Hum Mol Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1172\/JCI31330","article-title":"A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis","volume":"117","author":"Ichikawa","year":"2007","journal-title":"J Clin Invest."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/ajmg.a.37731","article-title":"Hartsfield syndrome associated with a novel heterozygous missense mutation in FGFR1 and incorporating tumoral calcinosis","volume":"170","author":"Prasad","year":"2016","journal-title":"Am J Med Genet A."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1172\/JCI122004","article-title":"Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodies","volume":"128","author":"Roberts","year":"2018","journal-title":"J Clin Invest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1210\/en.2008-0877","article-title":"Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression","volume":"150","author":"Ichikawa","year":"2009","journal-title":"Endocrinology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1210\/en.2011-1137","article-title":"Dietary phosphate restriction normalizes biochemical and skeletal abnormalities in a murine model of tumoral calcinosis","volume":"152","author":"Ichikawa","year":"2011","journal-title":"Endocrinology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1002\/jbmr.2242","article-title":"High dietary phosphate intake induces development of ectopic calcifications in a murine model of familial tumoral calcinosis","volume":"29","author":"Ichikawa","year":"2014","journal-title":"J Bone Miner Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e43205","DOI":"10.1371\/journal.pone.0043205","article-title":"A mouse with an N-Ethyl-N-nitrosourea (ENU) induced Trp589Arg Galnt3 mutation represents a model for hyperphosphataemic familial tumoural calcinosis","volume":"7","author":"Esapa","year":"2012","journal-title":"PLoS ONE."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/jbmr.2870","article-title":"Phenotypic and genotypic characterization and treatment of a cohort with familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome","volume":"31","author":"Ramnitz","year":"2016","journal-title":"J Bone Miner Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/00003086-198309000-00036","article-title":"Chemical, microscopic, and ultrastructural characterization of the mineral deposits in tumoral calcinosis","volume":"1983","author":"Boskey","year":"","journal-title":"Clin Orthop Relat Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/0002-9610(60)90496-7","article-title":"Calcinosis","volume":"99","author":"Annamunthodo","year":"1960","journal-title":"Am J Surg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00402-004-0715-0","article-title":"A case of familial tumoral calcinosis in a neonate and review of the literature","volume":"124","author":"Polykandriotis","year":"2004","journal-title":"Arch Orthop Trauma Surg."},{"key":"B22","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/ajmg.a.33337","article-title":"Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations","author":"Ichikawa","year":"2010","journal-title":"Am J Med Genet A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1530\/EJE-08-0011","article-title":"A novel missense mutation in GALNT3 causing hyperostosis-hyperphosphataemia syndrome","volume":"158","author":"Olauson","year":"2008","journal-title":"Eur J Endocrinol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1210\/jc.2016-1087","article-title":"Topical sodium thiosulfate: a treatment for calcifications in hyperphosphatemic familial tumoral calcinosis?","volume":"101","author":"Jost","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/jcp.2005.026369","article-title":"Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family","volume":"59","author":"Campagnoli","year":"2006","journal-title":"J Clin Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1210\/jc.2006-0305","article-title":"The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis","volume":"91","author":"Garringer","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00223-015-9974-8","article-title":"Human preosteoblastic cell culture from a patient with severe tumoral calcinosis-hyperphosphatemia due to a new GALNT3 gene mutation: study of in vitro mineralization","volume":"96","author":"Masi","year":"2015","journal-title":"Calcif Tissue Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.2106\/JBJS.H.00783","article-title":"A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis","volume":"91","author":"Masi","year":"2009","journal-title":"J Bone Joint Surg Am."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1210\/jc.2006-1247","article-title":"Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene","volume":"91","author":"Ichikawa","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00439-005-0026-8","article-title":"A novel homozygous missense mutation in FGF23 causes familial tumoral calcinosis associated with disseminated visceral calcification","volume":"118","author":"Chefetz","year":"2005","journal-title":"Hum Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1001\/archopht.1988.01060130795020","article-title":"Band keratopathy and calcific lid lesions in tumoral calcinosis. Case reports","volume":"106","author":"Bruns","year":"1988","journal-title":"Arch Ophthalmol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12863-014-0098-3","article-title":"Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; case report and review of the literature","volume":"15","author":"Rafaelsen","year":"2014","journal-title":"BMC Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/0002-9343(61)90131-0","article-title":"Heterotopic calcification, hyperphosphatemia and angioid streaks of the retina","volume":"31","author":"McPhaul","year":"1961","journal-title":"Am J Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00774-011-0260-1","article-title":"Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis","volume":"29","author":"Yancovitch","year":"2011","journal-title":"J Bone Miner Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IAE.0000000000002327","article-title":"Angioid streaks: a comprehensive review from pathophysiology to treatment","volume":"39","author":"Chatziralli","year":"2019","journal-title":"Retina."},{"key":"B36","doi-asserted-by":"publisher","first-page":"bcr0520103044","DOI":"10.1136\/bcr.05.2010.3044","article-title":"An ocular presentation of familial tumoral calcinosis","volume":"2010","author":"McGrath","year":"2010","journal-title":"BMJ Case Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/BF02944354","article-title":"A report of familial hyperphosphataemia in an Irish family","volume":"168","author":"Li Voon Chong","year":"1999","journal-title":"Ir J Med Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1093\/ndt\/gfu324","article-title":"Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing","volume":"29","author":"Shah","year":"2014","journal-title":"Nephrol Dial Transplant."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1210\/jc.2009-0961","article-title":"Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis","volume":"94","author":"Bergwitz","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"B40","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1600-0714.1991.tb00423.x","article-title":"Dental lesions in tumoral calcinosis","volume":"20","author":"Burkes","year":"1991","journal-title":"J Oral Pathol Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1346-8138.1996.tb02649.x","article-title":"Tumoral calcinosis: report of a case and brief review of the literature","volume":"23","author":"Abraham","year":"1996","journal-title":"J Dermatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"416","DOI":"10.12968\/denu.2012.39.6.416","article-title":"Tumoral calcinosis: a dental literature review and case report","volume":"39","author":"Krstevska","year":"2012","journal-title":"Dent Update."},{"key":"B43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0030-4220(89)90123-0","article-title":"Tumoral calcinosis with unusual dental radiographic findings","volume":"68","author":"Witcher","year":"1989","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/sj.bdj.4803099","article-title":"Developmental abnormalities of the dentine and pulp associated with tumoral calcinosis","volume":"135","author":"Hunter","year":"1973","journal-title":"Br Dent J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00198-008-0775-z","article-title":"A case of familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features","volume":"20","author":"Dumitrescu","year":"2009","journal-title":"Osteoporos Int."},{"key":"B46","doi-asserted-by":"publisher","first-page":"134","DOI":"10.12968\/denu.2008.35.2.134","article-title":"Tumoral calcinosis with dental manifestations\u2013a case report","volume":"35","author":"Naikmasur","year":"2008","journal-title":"Dent Update."},{"key":"B47","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S1079-2104(05)80314-2","article-title":"Gaining access to calcified canals","volume":"79","author":"Stewart","year":"1995","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1016\/j.oooo.2015.05.006","article-title":"Root anomalies and dentin dysplasia in autosomal recessive hyperphosphatemic familial tumoral calcinosis (HFTC)","volume":"120","author":"Vieira","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/0030-4220(94)90279-8","article-title":"Head and neck manifestations of tumoral calcinosis","volume":"77","author":"Gal","year":"1994","journal-title":"Oral Surg Oral Med Oral Pathol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"569","DOI":"10.12659\/AJCR.892113","article-title":"Hyperphosphatemic familial tumoral calcinosis: odontostomatologic management and pathological features","volume":"15","author":"Favia","year":"2014","journal-title":"Am J Case Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11282-016-0237-9","article-title":"Dental findings of hyperphosphatemic familial tumoral calcinosis","volume":"33","author":"Yilanci Hoa","year":"2017","journal-title":"Oral Radiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fendo.2018.00189","article-title":"FGF23 actions on target tissues-with and without Klotho","volume":"9","author":"Richter","year":"2018","journal-title":"Front Endocrinol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2106\/JBJS.G.01512","article-title":"Familial tumoral calcinosis: a forty-year follow-up on one family","volume":"91","author":"Carmichael","year":"2009","journal-title":"J Bone Joint Surg Am."},{"key":"B54","volume-title":"The National Academies Collection: Reports Funded by National Institutes of Health. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride.","year":"1997"},{"key":"B55","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3945\/an.115.008516","article-title":"Phosphorus","volume":"6","author":"Calvo","year":"2015","journal-title":"Adv Nutr."},{"key":"B56","doi-asserted-by":"publisher","first-page":"422","DOI":"10.7326\/M17-2640","article-title":"Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017. Clinical practice guideline update","volume":"168","author":"Ketteler","year":"2018","journal-title":"Ann Intern Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1001\/archpedi.1985.02140100078036","article-title":"Elevated serum calcitriol concentrations do not fall in response to hyperphosphatemia in familial tumoral calcinosis","volume":"139","author":"Steinherz","year":"1985","journal-title":"Am J Dis Child."},{"key":"B58","doi-asserted-by":"publisher","first-page":"247s","DOI":"10.1016\/S8756-3282(95)80001-8","article-title":"Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide","volume":"16","author":"Yamaguchi","year":"1995","journal-title":"Bone."},{"key":"B59","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000197876","article-title":"Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer","volume":"71","author":"Lammoglia","year":"2009","journal-title":"Horm Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1298674","DOI":"10.1155\/2019\/1298674","article-title":"Lanthanum-induced radiopaque intestinal precipitates: a potential cause of intestinal foreign bodies","volume":"2019","author":"Galo","year":"2019","journal-title":"Case Rep Nephrol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/ajmg.a.36476","article-title":"Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms","author":"Finer","year":"2014","journal-title":"Am J Med Genet A."},{"key":"B62","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bone.2014.06.036","article-title":"Nicotinamide treatment in a murine model of familial tumoral calcinosis reduces serum Fgf23 and raises heart calcium","volume":"67","author":"Reilly","year":"2014","journal-title":"Bone."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00467-018-3945-z","article-title":"Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?","volume":"33","author":"Claramunt-Taberner","year":"2018","journal-title":"Pediatr Nephrol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e10185","DOI":"10.1002\/jbm4.10185","article-title":"Hyperphosphatemic familial tumoral calcinosis with Galnt3 mutation: transient response to anti-interleukin-1 treatments","volume":"3","author":"Dauchez","year":"2019","journal-title":"JBMR Plus."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.2215\/CJN.04990513","article-title":"Sodium thiosulfate: mythical treatment for a mysterious disease?","volume":"8","author":"O'Neill","year":"2013","journal-title":"Clin J Am Soc Nephrol."},{"key":"B66","first-page":"63","article-title":"Successful sodium thiosulphate treatment for recurrent calcium urolithiasis","volume":"23","author":"Yatzidis","year":"1985","journal-title":"Clin Nephrol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1111\/ced.13782","article-title":"Topical sodium thiosulfate for calcinosis cutis associated with autoimmune connective tissue diseases: the Mayo Clinic experience, 2012-2017","volume":"44","author":"Ma","year":"2019","journal-title":"Clin Exp Dermatol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.semarthrit.2017.05.013","article-title":"Efficacy of intralesional sodium thiosulfate injections for disabling tumoral calcinosis: two cases","volume":"47","author":"Goossens","year":"2017","journal-title":"Semin Arthritis Rheum."},{"key":"B69","first-page":"408","article-title":"Sodium thiosulfate for the treatment of calcinosis secondary to juvenile dermatomyositis","volume":"32","author":"Pagnini","year":"2014","journal-title":"Clin Exp Rheumatol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.2215\/CJN.09880912","article-title":"Sodium thiosulfate therapy for calcific uremic arteriolopathy","volume":"8","author":"Nigwekar","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF03349921","article-title":"Effects of the acute subcutaneous administration of synthetic salmon calcitonin in tumoral calcinosis","volume":"12","author":"Candrina","year":"1989","journal-title":"J Endocrinol Invest."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1681\/ASN.2018121250","article-title":"Pharmacological Npt2a inhibition causes phosphaturia and reduces plasma phosphate in mice with normal and reduced kidney function","volume":"30","author":"Thomas","year":"2019","journal-title":"J Am Soc Nephrol."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00293\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T01:12:53Z","timestamp":1588900373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00293\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":72,"alternative-id":["10.3389\/fendo.2020.00293"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00293","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"article-number":"293"}}